EUVIMEDEUVIMED entdecken
Crossref

Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation

He Ma, Jia-Rui Zheng, Xin-Kun Liu, Lin-Xiang Huang, Yan-Di Xie, Bo Feng

Journal of Clinical and Translational Hepatology · 17.11.2026

DOI: 10.14218/jcth.2026.00549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Clinical and Translational Hepatology, online erschienen am 17.11.2026. Verfasst von He Ma und 5 weiteren Autor:innen. Die Arbeit nennt 102 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Achieving a functional cure for chronic hepatitis B remains challenging, primarily due to the inability to reconstitute effective host immune responses against the virus. The unexpected functional cure of chronic hepatitis B following allogeneic hematopoietic stem cell transplantation provides a unique proof-of-principle model for immune-mediated HBsAg clearance. This review aims to elucidate that the core mechanism underlying hematopoietic stem cell transplantation-mediated HBsAg clearance lies in “adoptive immune transfer”, and to explore design principles and future directions for modern cell-based immunotherapies based on this mechanism. We reviewed available case reports and meta-analytic evidence, acknowledging their limitations, and dissected the immunological mechanisms by which donor-derived hepatitis B virus-specific T and B cells may jointly reconstitute adaptive immunity and break host immune tolerance. We then comparatively evaluated the technical characteristics and limitations of chimeric antigen receptor T cell therapy and T-cell receptor-engineered T-cell therapy. Current engineered T-cell therapies, while translating the core principle of adoptive transfer, exhibit fundamental limitations including monoclonal specificity, inability to remodel the host microenvironment, and absence of durable humoral reconstitution. A broader functional-cure strategy may require adopting the paradigm of synergy and systemic immune reshaping exemplified by hematopoietic stem cell transplantation. Future strategies should develop temporally optimized, multilayered combination therapies, offering a possible pathway for next-generation therapeutics capable of systemically rebuilding antiviral immunity.

Zitieren

APA

Ma, H., Zheng, J., Liu, X., Huang, L., Xie, Y., & Feng, B. (2026). Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation. Journal of Clinical and Translational Hepatology. https://doi.org/10.14218/jcth.2026.00549

Vancouver

Ma H, Zheng J, Liu X, Huang L, Xie Y, Feng B. Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation. Journal of Clinical and Translational Hepatology. 2026. doi:10.14218/jcth.2026.00549

BibTeX
@article{Ma2026,
  author = {Ma, He and Zheng, Jia-Rui and Liu, Xin-Kun and Huang, Lin-Xiang and Xie, Yan-Di and Feng, Bo},
  title = {Adoptive Immune Transfer in the Functional Cure of Chronic Hepatitis B: Insights from Hematopoietic Stem Cell Transplantation},
  journal = {Journal of Clinical and Translational Hepatology},
  year = {2026},
  doi = {10.14218/jcth.2026.00549}
}
Kostenlos starten →